RSV is a virus which commonly causes low respiratory tract infection. Human and infants are more prone to RSV infection as this affects the heart and immune systems resulting in serious illness. The RSV diagnostics market was valued at $0.65 billion in 2017 and is anticipated to reach $1.42 billion by the end of 2024, growing with CAGR of 10.45%. The factors driving the market growth are increasing approval of RSV Diagnostics kits and assays, growing demand for point-of-care molecular diagnostic tests, increasing burden of RSV infections and technological advancements in diagnostic methods. Whereas, the factors such as shortage of specific treatment options and development of vaccines for RSV in the future are restraining the market growth.
Research Study Objectives:
- Define, estimate, and forecast the RSV Diagnostics market statistics by product, method, end-user and regions concerning the individual growth drivers, market trends and their contribution toward the RSV Diagnostics market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the RSV Diagnostics Market Analysis
- Analysis and conclusions on the future RSV Diagnostics market outlook.
Top-down and bottom-up approaches are used to validate the RSV Diagnostics Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the
market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The RSV Diagnostics Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the RSV Diagnostics market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The RSV Diagnostics market segmentation is as follows:
By Product
- Instruments
- Kits & Assays
- Others
By Method
- Rapid Antigen Detection Tests
- Molecular Diagnostics
- Immunofluorescence Assays
- Enzyme-Linked Immunosorbent Assays
- Others
- Optical Immunoassays
- Chromatographic Immunoassays
- Others
By End-user
- Clinical Laboratories
- Hospitals and Clinics
- Home Care
- Others
Geographical Analysis:
RSV Diagnostics Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East
& African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the RSV Diagnostics Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global RSV Diagnostics Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOTanalysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant RSV Diagnostics market players, such as
- Danaher Corporation
- Becton, Dickinson and Company (BD)
- Thermo Fisher Scientific Corporation
- Roche Holding AG
- Biomérieux, Inc.
- Along with these companies, many other companies are considered in the report while analysing the Global RSV Diagnostics competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
